Characterization of pelvic and cervical microbiotas from patients with pelvic inflammatory disease-Reference-Cited by-同舟云学术

Characterization of pelvic and cervical microbiotas from patients with pelvic inflammatory disease

Published:2018-10-01 Issue:10 Volume:67 Page:1519-1526
ISSN:0022-2615
Container-title:Journal of Medical Microbiology
language:en
Short-container-title:

Author:

Wang Yue¹,Zhang Ye²³,Zhang Qi²³,Chen Huan⁴,Feng Ye⁴²³

Affiliation:

1. 1Department of Gynecology, Women’s Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, PR China

2. 2Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, PR China

3. 3Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou, Zhejiang, PR China

4. 4Key Laboratory of Microbial Technology and Bioinformatics of Zhejiang Province, Hangzhou, Zhejiang, PR China

Publisher

Microbiology Society

Subject

Microbiology (medical),General Medicine,Microbiology

Reference28 articles.

1. Pelvic Inflammatory Disease

2. Chlamydia infection, pelvic inflammatory disease, ectopic pregnancy and infertility: cross-national study

3. Update on the Management of Gonorrhea in Adults in the United States

4. Trends in Pelvic Inflammatory Disease Hospital Discharges and Ambulatory Visits, United States, 1985–2001

5. Present situation and prospects of reproductive tract infections and sexually transmitted infections in Chinese women;Liao;Zhonghua Fu Chan Ke Za Zhi,2007

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of the female genital tract and gut microbiome on reproductive dysfunction;BioScience Trends;2023-12-31

2. Features of vaginal microbiota in women at different stages of postmenopause;Gynecology;2023-12-20

3. Characteristics Of Acute Pelvic Inflammatory Disease In Surgically Treated Females Over Ten years - A Single-Center Study;Current Women s Health Reviews;2023-05-18

4. Management of Pelvic Inflammatory Disease in Clinical Practice;Therapeutics and Clinical Risk Management;2023-02

5. Microbiota and its therapeutic implications in reproductive health and diseases;Microbiome Therapeutics;2023